Loading...
Loading...
NEW YORK, NY · CIK 0001263508
Portfolio Value
$14.71B
Positions
106
New
12
Increased
16
Decreased
17
Sold Out
4
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $14.71B across 106 positions in their Q2 2019 SEC 13F filing (period ending 2019-06-30). The top 10 positions account for 84.4% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENEURSeattle Genetics, Inc. | $3.46B | 23.55% | -1.9% |
| 2 | INCYIncyte Corporation | $2.72B | 18.46% | -6.7% |
| 3 | ONCBeiGene, Ltd. | $1.46B | 9.92% | -1.5% |
| 4 | ALXNAlexion Pharmaceuticals, Inc. | $1.08B | 7.35% | -3.5% |
| 5 | ACADACADIA Pharmaceuticals Inc. | $1.05B | 7.14% | -1.1% |
| 6 | Amarin Corporation plc | $805.54M | 5.47% | -3.9% |
| 7 | BMRNBioMarin Pharmaceutical Inc. | $650.02M | 4.42% | - |
| 8 | GHDXGenomic Health, Inc. | $538.71M | 3.66% | -9.2% |
| 9 | ASNDUSDAscendis Pharma A/S | $390.39M | 2.65% | - |
| 10 | MRTXEURMirati Therapeutics, Inc. | $258.89M | 1.76% | - |
| Stock | Value | Shares |
|---|---|---|
| BCELUSDAtreca, Inc. | $66.56M | 3,532,760 |
| ADPTAdaptive Biotechnologies Corporation | $56.29M | 1,165,411 |
| MISTMilestone Pharmaceuticals Inc. | $7.24M | 266,667 |
| HOOKHOOKIPA Pharma Inc. | $6.01M | 892,857 |
| NGMUSDNGM Biopharmaceuticals, Inc. | $3.66M | 250,000 |
| XBITXBiotech Inc. | $2.88M | 380,442 |
| CYCNUSDCyclerion Therapeutics, Inc. | $2.32M | 202,581 |
| NXTCNextCure, Inc. | $2.25M | 150,000 |
| NXTCEURNextCure, Inc. | $2.25M | 150,000 |
| IDYAIDEAYA Biosciences, Inc. | $1.99M | 200,000 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.